CDE vs. BIB
CDE (Coeur Mining, Inc.) is a stock, while BIB (ProShares Ultra Nasdaq Biotechnology) is Leveraged Equities fund tracking the NASDAQ Biotechnology Index (200%). Over the past 10 years, CDE returned 1.19%/yr vs 7.33%/yr for BIB. Their 0.23 correlation means their historical movements had little consistent relationship.
Performance
CDE vs. BIB - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CDE achieves a -2.13% return, which is significantly lower than BIB's 27.73% return. Over the past 10 years, CDE has underperformed BIB with an annualized return of 1.19%, while BIB has yielded a comparatively higher 7.33% annualized return.
CDE
- 1D
- 7.53%
- 1M
- 2.59%
- 6M
- -15.91%
- YTD
- -2.13%
- 1Y
- 78.97%
- 3Y*
- 84.91%
- 5Y*
- 20.18%
- 10Y*
- 1.19%
- ALL TIME*
- -7.11%
BIB
- 1D
- 1.72%
- 1M
- -4.18%
- 6M
- 19.55%
- YTD
- 27.73%
- 1Y
- 98.74%
- 3Y*
- 26.81%
- 5Y*
- -0.08%
- 10Y*
- 7.33%
- ALL TIME*
- 17.65%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $545.85K | $915.16K | $959.35K | |
| $547.56M | $455.55M | $551.13M |
CDE vs. BIB - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
CDE Coeur Mining, Inc. | -2.13% | 211.71% | 75.46% | -2.98% | -33.33% | -51.30% | 28.09% | 80.76% | -40.40% | -17.49% |
BIB ProShares Ultra Nasdaq Biotechnology | 27.73% | 59.21% | -9.84% | -1.06% | -28.85% | -6.02% | 39.79% | 46.71% | -24.93% | 40.49% |
Correlation
The correlation between CDE and BIB is 0.29, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.29 |
Correlation (3Y) Balances recent behavior with more history. | 0.27 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.28 |
Correlation (10Y) Provides a long-term view across more market conditions. | 0.26 |
Correlation (All Time) Calculated using the full available price history since Apr 8, 2010 | 0.23 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CDE vs. BIB — Risk / Return Rank
CDE
BIB
CDE vs. BIB - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Coeur Mining, Inc. (CDE) and ProShares Ultra Nasdaq Biotechnology (BIB). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CDE | BIB | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.37 | ||
| Sortino ratioReturn per unit of downside risk | -1.30 | ||
| Omega ratioGain probability vs. loss probability | 1.22 | 1.36 | -0.14 |
| Calmar ratioReturn relative to maximum drawdown | 1.66 | 5.87 | -4.21 |
| Martin ratioReturn relative to average drawdown | 2.97 | 16.36 | -13.38 |
Loading charts...
Drawdowns
CDE vs. BIB - Drawdown Comparison
The maximum CDE drawdown since its inception was -99.40%, which is greater than BIB's maximum drawdown of -67.24%. Use the drawdown chart below to compare losses from any high point for CDE and BIB.
Loading charts...
Drawdown Indicators
| CDE | BIB | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.40% | -67.24% | -32.16% |
Max Drawdown (1Y)Largest decline over 1 year | -47.79% | -16.92% | -30.87% |
Max Drawdown (3Y)Largest decline over 3 years | -47.79% | -45.30% | -2.49% |
Max Drawdown (5Y)Largest decline over 5 years | -72.43% | -65.86% | -6.57% |
Max Drawdown (10Y)Largest decline over 10 years | -87.42% | -66.20% | -21.22% |
Current DrawdownCurrent decline from peak | -93.95% | -7.23% | -86.72% |
Average DrawdownAverage peak-to-trough decline | -81.54% | -32.53% | -49.01% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 26.64% | 6.06% | +20.58% |
Volatility
CDE vs. BIB - Volatility Comparison
Coeur Mining, Inc. (CDE) has a higher volatility of 19.22% compared to ProShares Ultra Nasdaq Biotechnology (BIB) at 10.96%. This indicates that CDE's price experiences larger fluctuations and is considered to be riskier than BIB based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CDE | BIB | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 19.22% | 10.96% | +8.26% |
Volatility (6M)Calculated over the trailing 6-month period | 52.77% | 31.57% | +21.20% |
Volatility (1Y)Calculated over the trailing 1-year period | 73.62% | 40.58% | +33.04% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 68.85% | 43.70% | +25.15% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 68.90% | 46.31% | +22.59% |
Dividends
CDE vs. BIB - Dividend Comparison
CDE's dividend yield for the trailing twelve months is around 0.11%, less than BIB's 0.32% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
BIB ProShares Ultra Nasdaq Biotechnology | 0.32% | 0.77% | 1.69% | 0.07% | 0.03% |
CDE Coeur Mining, Inc. | 0.11% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
CDE and BIB have a correlation of 0.29, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
CDE has higher volatility (19.22%) compared to BIB (10.96%). In terms of maximum drawdown, CDE dropped -99.40% vs BIB's -67.24%.
BIB currently has the higher Sharpe Ratio (2.45 vs 1.08), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for CDE and BIB
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer